Saturday, February 27, 2021
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Policy + Initiatives

Obama Signs Pandemics and All-Hazards Preparedness Act of 2013

by Global Biodefense Staff
March 14, 2013

Pandemic PreparednessThe Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) of 2013 was signed into law yesterday by President Barack Obama. The legislation reauthorizes provisions of the Project Bioshield Act of 2004 and the Pandemic and All-Hazards Preparedness Act (PAHPA) of 2006 for an additional five years.

The law extends the mandate of the Biomedical Advanced Research and Development Authority (BARDA) to support medical countermeasure development for biothreat agents for possible inclusion in the U.S. Strategic National Stockpile. PAHPRA also enhances the authority of the U.S. Food and Drug Administration to support rapid responses to public health emergencies by clarifying that even before an event, FDA may issue an emergency use authorization to allow emergency use of certain products as medical countermeasures.

PAHPRA also provides funding for a variety of public health and medical preparedness programs. “With the reauthorization, communities can continue to count on our National Disaster Medical System, now more than 7,000 personnel strong, to bring medical professionals from across the country to provide care and support hospitals, shelters, and communities after a disaster,” stated Assistant Secretary Nicole Lurie from the U.S. Department of Health and Human Services.

The act grants new authorities to state health departments for more flexibility in dedicating resources to meet critical community needs in a disaster. States may now choose to temporarily deploy federally funded state personnel whose day-to-day jobs are not related directly to emergencies, to meet immediate urgent needs. For example, staff paid through HIV grant funding could be deployed for a short term to provide care for the public during a pandemic.

The Congressional Budget Office estimated implementation of the bill will cost $11 billion between fiscal years 2014 to 2018.

Tags: BARDAPandemicStrategic National Stockpile

Related Posts

US Must Unify Atmospheric Biology Research or Risk National Security
Biosecurity

US Must Unify Atmospheric Biology Research or Risk National Security

January 30, 2021
Travelers From Italy May Have Driven First US COVID-19 Wave More Than Those From China
Biosecurity

Travelers From Italy May Have Driven First US COVID-19 Wave More Than Those From China

January 30, 2021
The Next Once-a-century Pandemic is Coming Sooner Than You Think – But COVID-19 Can Help Us Get Ready
Biosecurity

Heading Off The Next Pandemic

January 4, 2021
Celdara’s Pandemic Security Initiative Introduces Scientific Advisory Board Founding Members
Health Security

Celdara’s Pandemic Security Initiative Introduces Scientific Advisory Board Founding Members

November 5, 2020
Load More

Latest News

First Human Trial of COVID-19 Vaccine Finds it is Safe and Induces Rapid Immune Response

COVID-19 Vaccination: What We Can Learn From the Great Polio Vaccine Heist of 1959

February 24, 2021
Sign on street in Conakry that says Ebola in large letters

Why Ebola is Back in Guinea and Why the Response Must Be Different This Time

February 24, 2021
How Roald Dahl Became a Passionate Vaccine Advocate

How Roald Dahl Became a Passionate Vaccine Advocate

February 23, 2021
How Do We Know the COVID Vaccine Won’t Have Long-Term Side-Effects?

How Do We Know the COVID Vaccine Won’t Have Long-Term Side-Effects?

February 23, 2021

Upcoming Events

Mar 1
Virtual Event
All day

Rare Disease Day at NIH 2021 – Virtual Conference

Mar 2
Virtual Event
March 2 - March 5

Effectiveness of Non-Vaccine Influenza Control Measures

Mar 2
Virtual Event
4:00 pm - 6:00 pm

RNA Viruses: How They Do What They Do

Mar 2
Virtual Event
5:00 pm - 7:00 pm

COVID Seminar Series – Hindsight is 2020

Mar 4
Virtual Event
10:00 am - 1:30 pm

Vulnerabilities in U.S. Chemical Weapons Detection, Identification, and Tracing

View More
Tweets by GlobalBioD

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2021 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
    • All Events
    • Deadlines
    • Webinar-Webcast
    • Awareness Events
  • Subscribe

© 2021 Stemar Media Group LLC